Filovirus Family: Recent Advances and Future Directions

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 162

Special Issue Editor


E-Mail Website
Guest Editor
School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA
Interests: viral entry and antiviral entry; viral vaccines; filoviruses; retroviruses

Special Issue Information

Dear Colleagues,

The filovirus family (Filoviridae) is a unique group of single-stranded negative-sense RNA viruses with filamentous forms, which currently includes the six genera Cuevavirus, Dianlovirus, Ebolavirus, Marburgvirus, Striavirus, and Thamnovirus. Two major genera, Ebolavirus and Marburgvirus, are well known because they have caused a number of fatal outbreaks since they were first discovered in 1976 and 1967, respectively. Filoviruses are emerging or re-emerging infectious viruses. In particular, the more frequent outbreaks of Ebolavirus and the re-emergence of Marburgvirus in Guinea and Ghana last year signify the risks from these filoviruses, which may cause an unprecedented epidemic and pose a serious threat to public health. This Special Issue entitled “Filovirus Family: Recent Advances and Future Directions” is to promote studies on this group of viruses. We would like to review our research experiences and lessons over the past 50 years and how we can more efficiently conduct our research to meet the challenges we are facing in combating these deadly viruses. 

Reviews may include basic research such as viral entry and pathogenesis, virus–host interactions, and viral evolution and transmission, and anti-viral research such as vaccines and drugs or other novel countermeasures for filoviruses. Furthermore, in vivo and in vitro models are also necessary for studying these select viral pathogens.  

Dr. Shi-hua Xiang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • filoviruses
  • infection and pathogenesis
  • animal models
  • evolution and transmission
  • vaccines and therapeutics

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop